You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 24, 2025

Patent: 7,776,844


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,776,844
Title:N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
Abstract: The present invention relates to an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof, the N-(phosphonoalkyl)-amino acid, related compound or derivative thereof being in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, other than N-(phosphonomethyl)-glycine or N,N-bis(phosphonomethyl)-glycine. Also included is a composition including an N-(phosphonoalkyl)-amino acid, a related compound or a derivative thereof in a form as a free acid, salt, partial salt, lactone, amide or ester, or in stereoisomeric or non-stereoisomeric form, and a cosmetically or pharmaceutically acceptable vehicle for topical or systemic administration to a mammalian subject, as well as a method of administering an effective amount of such a composition for alleviating or improving a condition, disorder, symptom or syndrome associated with at least one of a nervous, vascular, musculoskeletal or cutaneous system.
Inventor(s): Yu; Ruey J. (Chalfont, PA), Van Scott; Eugene J. (Abington, PA)
Application Number:12/428,906
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 7,776,844

Introduction

United States Patent 7,776,844, hereafter referred to as the '844 patent, is a significant patent that has contributed to the intellectual property landscape in the United States. This analysis will delve into the claims of the patent, its technological context, and the broader patent landscape it operates within.

Background of the Patent

To begin with, it is crucial to understand the background and the technological area the '844 patent pertains to. However, since the specific details of this patent are not provided in the sources, we will generalize the analysis based on common practices and principles in patent law and technology.

Claims Analysis

Understanding Patent Claims

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. The claims must be clear, concise, and definite to meet the requirements of 35 U.S.C. § 112(b)[5].

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: These claims describe a process or method of achieving a particular result.
  • Apparatus Claims: These claims describe a physical device or system.

Claim Construction

The construction of claims is critical for determining the patent's scope. The courts use a two-step process to interpret claims: first, determining the ordinary and customary meaning of the claim terms, and second, considering any special definitions provided in the specification or file history[5].

Technological Context

Classification and Technology Areas

Patents are often classified under specific technology areas using the International Patent Classification (IPC) system. This classification helps in understanding the broader technological landscape and the relevance of the patent within its field. For example, patents related to Information and Communication Technology (ICT) or software are commonly classified under specific IPC codes[1].

Patent Eligibility

Statutory Requirements

For a patent to be granted, the invention must meet several statutory requirements, including novelty (35 U.S.C. § 102), non-obviousness (35 U.S.C. § 103), and subject matter eligibility (35 U.S.C. § 101)[5].

Subject Matter Eligibility

The subject matter eligibility requirement has been a point of contention, particularly after the U.S. Supreme Court's decision in Alice v. CLS Bank. This decision introduced a two-part test to determine whether a patent application recites patentable subject matter, which has been challenging to apply consistently[5].

Recent Developments in Patent Law

2024 USPTO Guidance Update on AI Patents

The USPTO's 2024 guidance update on AI patents is significant for understanding how AI-related inventions are evaluated for patent eligibility. This update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[2].

Patent Assertion Entities (PAEs)

Impact on the Patent Landscape

PAEs, also known as "patent trolls," play a significant role in the patent landscape. They can be categorized into two main types: Portfolio PAEs and Litigation PAEs. Portfolio PAEs negotiate licenses covering large portfolios without necessarily suing, while Litigation PAEs often engage in nuisance litigation to secure licenses. This activity can significantly impact the cost and complexity of patent enforcement and defense[3].

Geographical and Economic Analysis

County-Level Patent Data

The analysis of patent data at the county level can provide insights into regional innovation and economic activity. This data can be analyzed based on the location of the inventor or the owner of the patent, allowing for different kinds of economic and regional analyses[1].

Determining Inventorship

Conception and Reduction to Practice

Inventorship in U.S. patent law focuses on the conception of the idea and the reduction to practice. Conception is complete when the idea is sufficiently definite and permanent to permit one with ordinary skill in the field to reduce it to practice without undue experimentation. Errors in inventorship can have serious consequences, including the invalidation of the patent if there is deceptive intent[4].

Strengthening the U.S. Intellectual Property System

Actions for Improvement

Experts recommend several actions to strengthen the U.S. intellectual property system, including clarifying patent eligibility requirements, improving data collection and transparency, and addressing the challenges posed by PAEs. These actions aim to create a more predictable and reliable IP ecosystem[5].

Key Takeaways

  • Clear Claims: The clarity and definiteness of patent claims are crucial for determining the scope of the invention.
  • Technological Context: Understanding the technological area and classification of the patent helps in assessing its relevance and impact.
  • Patent Eligibility: Meeting statutory requirements, especially subject matter eligibility, is essential for patent validity.
  • AI and Patent Law: Recent updates clarify the evaluation of AI-related inventions, ensuring they are treated equally with other technologies.
  • PAEs: The activities of PAEs can significantly affect the patent landscape, particularly in terms of litigation and licensing.
  • Geographical Analysis: County-level patent data can provide valuable insights into regional innovation and economic activity.
  • Inventorship: Accurate determination of inventorship is vital to the validity and enforceability of a patent.

FAQs

Q: What are the key statutory requirements for a patent to be granted in the United States? A: The key statutory requirements include novelty (35 U.S.C. § 102), non-obviousness (35 U.S.C. § 103), and subject matter eligibility (35 U.S.C. § 101).

Q: How does the 2024 USPTO guidance update impact AI-related patent applications? A: The update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility, ensuring AI-assisted inventions are evaluated equally with other technologies.

Q: What is the difference between Portfolio PAEs and Litigation PAEs? A: Portfolio PAEs negotiate licenses covering large portfolios without suing, while Litigation PAEs engage in nuisance litigation to secure licenses.

Q: Why is accurate inventorship determination important in patent law? A: Accurate inventorship is crucial because errors can lead to the invalidation of the patent, especially if there is deceptive intent.

Q: How can county-level patent data be used in economic analysis? A: County-level patent data can be analyzed based on the location of the inventor or the owner, providing insights into regional innovation and economic activity.

Sources

  1. National Science Foundation. Invention, Knowledge Transfer, and Innovation. 2022.
  2. Mintz. Understanding the 2024 USPTO Guidance Update on AI Patent. 2024.
  3. Federal Trade Commission. Patent Assertion Entity Activity: An FTC Study. 2016.
  4. Oregon State University. Determining Inventorship for US Patent Applications.
  5. Center for Strategic and International Studies. Four Actions to Strengthen the U.S. Intellectual Property System. 2023.

More… ↓

⤷  Try for Free

Details for Patent 7,776,844

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Ferring Pharmaceuticals Inc. ACTHREL corticorelin ovine triflutate For Injection 020162 May 23, 1996 7,776,844 2026-01-10
Bayer Healthcare Pharmaceuticals Inc. TRASYLOL aprotinin Injection 020304 December 29, 1993 7,776,844 2026-01-10
Ony Biotech Inc. INFASURF calfactant Suspension 020521 July 01, 1998 7,776,844 2026-01-10
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.